Use the Back button in your browser to see the other results of your search or to select another record.
Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial |
Blay R, Flores LE, Kupzyk K, Waltman N, Lappe J, Mack L, Bilek L |
Osteoporosis International 2024 May;35(5):877-891 |
clinical trial |
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|